Clinical Trial Update: A Study Evaluating the Safety, Tolerability, Pharmacokinetics and Antiviral Activity of GS-6620 in Treatment Naïve Subjects With Chronic Hepatitis C Virus Infection [Phase 1]

View source ↗

Summary

Phase 1 study evaluating safety, tolerability, pharmacokinetics, and antiviral activity of GS-6620 in treatment-naïve subjects with chronic hepatitis C; the stu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• GS-6620

Snippet

Sponsor: Gilead Sciences | Conditions: Hepatitis C, Chronic | Phase 1 | Status: COMPLETED